Kane Biotech Receives $2.7 Million USD United States Department of Defense Award of DispersinB®
“We are thrilled to receive this MTEC Award, which we believe is a testament and preliminary validation to both the DispersinB® technology as well as the dire need for a non-healing chronic wound treatment,” said Marc Edwards, President and CEO